Compare FLYX.WS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
flyExclusive Inc. Redeemable warrants each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 per share
Current Price
Current Price
| Metric | FLYX.WS | LTRN |
|---|---|---|
| Founded | N/A | 2013 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 10.0M |
| IPO Year | N/A | 2020 |
| Metric | FLYX.WS | LTRN |
|---|---|---|
| Price | $0.14 | $0.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | N/A | ★ 218.7K |
| Earning Date | N/A | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $0.42 |
| 52 Week High | N/A | $4.34 |
| Indicator | FLYX.WS | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 25.41 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $0.84 |
| Average True Range (ATR) | 0.00 | 0.10 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 4.39 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.